|
|
||||||||
-mediated pathway
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455
The discovery of homologs of the brown
fat uncoupling protein(s) (UCP) UCP-2 and UCP-3 revived the hypothesis
of uncoupling protein involvement in the regulation of energy
metabolism. Thus we hypothesized that UCP-2 would be regulated in the
hepatocyte by fatty acids, which are known to control other
energy-related metabolic processes. Treatment with 250 µM palmitic
acid was without effect on UCP-2 expression, whereas 250 µM oleic
acid exhibited a modest eightfold increase. Eicosapentaenoic acid
(EPA), a polyunsaturated fatty acid, exerted a 50-fold upregulation of
UCP-2 that was concentration dependent. This effect was seen within
12 h and was maximal by 36 h. Aspirin blocked the induction
of UCP-2 by EPA, indicating involvement of the prostaglandin pathway.
Hepatocytes treated with arachidonic acid, the immediate precursor to
the prostaglandins, also exhibited an aspirin-inhibitable increase in
UCP-2 levels, further supporting the involvement of prostaglandins in
regulating hepatic UCP-2. The peroxisome proliferator-activated
receptor-
(PPAR
) agonist Wy-14643 stimulated UCP-2 mRNA levels as
effectively as EPA. These data indicate that UCP-2 is upregulated by
polyunsaturated fatty acids, potentially through a
prostaglandin/PPAR
-mediated pathway.
uncoupling protein; prostaglandins; energy metabolism; peroxisome
proliferator-activated receptor-
This article has been cited by other articles:
![]() |
Y. Ootsuka, W. W. Blessing, A. A. Steiner, and A. A. Romanovsky Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1294 - R1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Milne, C. J. Burns, P. E. Squires, N. D. Evans, J. Pickup, P. M. Jones, and S. J. Persaud Uncoupling of Nutrient Metabolism From Insulin Secretion by Overexpression of Cytosolic Phospholipase A2 Diabetes, January 1, 2005; 54(1): 116 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Jones, C. J. Burns, V. D. Belin, H. M. Roderigo-Milne, and S. J. Persaud The Role of Cytosolic Phospholipase A2 in Insulin Secretion Diabetes, February 1, 2004; 53(90001): S172 - 178. [Abstract] [Full Text] |
||||
![]() |
K. Eto, T. Yamashita, J. Matsui, Y. Terauchi, M. Noda, and T. Kadowaki Genetic Manipulations of Fatty Acid Metabolism in {beta}-Cells Are Associated With Dysregulated Insulin Secretion Diabetes, December 1, 2002; 51(90003): S414 - 420. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |